The University of Michigan School of Dentistry
Dr. Mishina’s laboratory is interested in functions of BMP signaling during bone development/remodeling and craniofacial development. They recently developed several mouse lines to conditionally decrease or increase levels of BMP signaling using a Cre-loxP system. When BMP signaling through BMP type IA receptor (BMPRIA) was specifically knocked out in osteoblasts, bone mass was increased, unlike what was predicted, by decrease of osteoclastogenesis. Molecular analyses revealed that BMP signaling in osteoblasts positively regulates expression of sclerostin, an inhibitor for Wnt signaling, in turn, negatively regulates Wnt signaling, subsequently influences OPG/RANKL pathway to support osteoclast functions. This would be an interesting model to understand pathogenesis of bone mass related diseases including osteoporosis and Sclerosis. When BMP signaling through BMPRIA was specifically activated in neural crest derived tissues, premature fusion of frontal suture was observed that lead to a morphological abnormality known as craniosinostosis. This phenotype was rescued in a heterozygous null background of Bmpr1a suggesting that amount of BMP signaling needs to be tightly regulated for normal development.Dr. Mishina’s laboratory is interested in functions of BMP signaling during bone development/remodeling and craniofacial development. They recently developed several mouse lines to conditionally decrease or increase levels of BMP signaling using a Cre-loxP system. When BMP signaling through BMP type IA receptor (BMPRIA) was specifically knocked out in osteoblasts, bone mass was increased, unlike what was predicted, by decrease of osteoclastogenesis. Molecular analyses revealed that BMP signaling in osteoblasts positively regulates expression of sclerostin, an inhibitor for Wnt signaling, in turn, negatively regulates Wnt signaling, subsequently influences OPG/RANKL pathway to support osteoclast functions. This would be an interesting model to understand pathogenesis of bone mass related diseases including osteoporosis and Sclerosis. When BMP signaling through BMPRIA was specifically activated in neural crest derived tissues, premature fusion of frontal suture was observed that lead to a morphological abnormality known as craniosinostosis. This phenotype was rescued in a heterozygous null background of Bmpr1a suggesting that amount of BMP signaling needs to be tightly regulated for normal development.
The Molecular Developmental Biology Group uses mouse genetics to study the function of the Bone Morphogenetic Proteins (BMPs) during mouse development.
One of the most sensitive targets of environmental toxicants is the early stage embryo. Prior to understanding the mechanisms by which environmental toxicants affect the embryos, researchers must first understand the mechanisms which control embryonic development, making the study of concerted gene function very important.
Developmental processes of vertebrate embryos are regulated, at least in part, by secretory molecules such as growth factors. The focus of the studies in the Molecular Developmental Biology group is on the function of BMPs during mouse development. BMPs are members of the Transforming Growth Factor-b (TGF-β) superfamily and were discovered by their ectopic bone-forming ability. However, recent findings demonstrate that BMPs have pleiotropic functions during embryogenesis, ranging from pattern formation to organogenesis. Extensive studies in humans have also revealed that mutations in BMP ligands, receptors and signaling molecules are involved in the pathogenesis of chondrodysplasia, hypertension and tumorigenesis. Members of the group are interested in understanding the roles that BMPs play in three major areas of embryogenesis: mineralized tissues, neural and neural crest-derived tissues, and body plan formation.
Early embryonic lethality is a problem that group members have encountered in BMP ligand and receptor mutant mice generated by regular gene disruption methods. Because of this problem, the Cre/loxP system was used to produce conditional (tissue-specific) gene mutations. The group’s research approaches should provide valuable insights into how the developmental processes in mineralized tissue, neural tissue and mesodermal tissue involved in body plan formation are regulated by growth factor signaling. The results of these studies may lead to the development of new ways of diagnosing and treating diseases and conditions such as osteoporosis, neural tube defects and failure in body plan pattern formation such as occurs in situs inversus.
The underlying hypothesis of the group’s research is that BMP signaling plays a critical role during the formation and maintenance of these tissues and alteration of BMP signaling causes malformation of the tissues. Successful alteration in the function of BMP-related genes—ligands, receptors, signaling molecules and downstream target genes—in a tissue- and stage-specific manner will lead to a greater understanding and a potential cure for diseases or lesions in the tissues of interest.
Yuji Mishina received his B.S., M.S. and Ph.D. degrees in Molecular Biology from University of Tokyo. He took a postdoctoral position at the University of Texas MD Anderson Cancer Center at Houston to learn mouse genetics and embryology. He served as a head of Molecular Developmental Biology Section in the Laboratory of Reproductive Developmental Toxicology at the National Institute of Environmental Health Sciences (Research Triangle Park, NC) for 10 years, and relocated to Michigan in 2008.
Yuji Mishina has a variety of experiences in developmental biology and mouse genetics including production of transgenic/knockout mouse. Current focuses are the functional analyses of growth factor signaling, especially that of Bone Morphogenetic Proteins, during bone development and bone remodeling, and craniofacial development.